Skip to main content

Want a detailed portfolio tracker?

Maze Therapeutics (MAZE) P/E (2025 - 2026)

Maze Therapeutics (MAZE) P/E from Mar 31, 2025 to Jul 21, 2026. The TTM Maze Therapeutics (MAZE) P/E is -11.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Maze Therapeutics (MAZE)

YearP/EChange
2026-11.35-22.10%
2025-14.57N/A

Comparison Maze Therapeutics (MAZE) P/E with competitors

Maze Therapeutics (MAZE) P/E is -11.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.66%
FGENFibroGen Inc0.24-102.11%
CHRSCoherus Biosciences Inc0.85-107.48%
FBIOFortress Biotech Inc0.95-108.36%
ORMPOramed Pharmaceuticals Inc1.50-113.24%
AGENAgenus Inc3.01-126.51%
INVAInnoviva Inc3.15-127.79%
VXRTVaxart Inc3.55-131.27%
CRMDCorMedix Inc3.63-131.97%
CVACCureVac N.V.4.45-139.17%
GLPGGalapagos NV4.86-142.81%
SRPTSarepta Therapeutics Inc4.88-143.01%
ABEOAbeona Therapeutics Inc5.39-147.46%
ABUSArbutus Biopharma Corp5.60-149.30%
ZVRAZevra Therapeutics Inc5.89-151.87%
SPROSpero Therapeutics Inc6.23-154.87%
CGENCompugen Ltd6.31-155.63%
RIGLRigel Pharmaceuticals6.87-160.54%
SLXNSilexion Therapeutics Corp7.30-164.28%
OMEROmeros Corporation9.26-181.57%
AUPHAurinia Pharmaceuticals Inc9.58-184.44%
PLXProtalix BioTherapeutics Inc10.89-195.95%
ACADAcadia Pharmaceuticals Inc11.73-203.33%
TBPHTheravance Biopharma Inc12.26-208.03%
ADMAAdma Biologics Inc12.42-209.40%
HRMYHarmony Biosciences Holdings Inc13.82-221.75%
SABSSAB Biotherapeutics Inc14.14-224.54%
NAGENiagen Bioscience Inc14.82-230.55%
INCYIncyte Corp15.82-239.40%
REGNRegeneron Pharmaceuticals Inc15.86-239.70%
PBYIPuma Biotechnology Inc17.32-252.55%
CPRXCatalyst Pharmaceuticals Inc17.44-253.64%
EXELExelixis Inc17.54-254.51%
TGTXTG Therapeutics Inc18.97-267.09%
MDXGMimedx Group Inc20.55-281.07%
XOMAXOMA Royalty Corp22.87-301.53%
ARGXArgen X SE24.30-314.07%
CTMXCytomX Therapeutics Inc24.82-318.68%
XOMAOXOMA Royalty Corp25.34-323.29%
HALOHalozyme Therapeutics Inc25.62-325.75%
XOMAPXOMA Royalty Corp25.67-326.16%
VRTXVertex Pharmaceuticals Inc27.99-346.64%
RPRXRoyalty Pharma plc - Class A28.69-352.74%
SLNOSoleno Therapeutics Inc29.02-355.63%
ASNDAscendis Pharma A/S30.09-365.06%
LGNDLigand Pharmaceuticals Inc - Class B37.91-434.01%
APLSApellis Pharmaceuticals Inc39.02-443.78%
BMRNBiomarin Pharmaceutical Inc42.21-471.89%
KRYSKrystal Biotech Inc45.34-499.48%
ONCBeiGene Ltd69.54-712.66%
PHARPharming Group N.V.75.03-760.99%
TECHBio-Techne Corp101.96-998.27%
VCELVericel Corp109.92-1068.42%
ALNYAlnylam Pharmaceuticals Inc117.96-1139.29%
GMABGenmab140.29-1335.98%
TLXTelix Pharmaceuticals Ltd162.15-1528.59%
CORTCorcept Therapeutics Inc212.86-1975.31%